Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
Barry R PalmerMelinda A PatersonChris M FramptonAnna P PilbrowLorraine SkeltonChris J PembertonRobert N DoughtyChris J EllisRichard W TroughtonA Mark RichardsVicky A CameronPublished in: PloS one (2021)
This study is strongly suggestive that VEGF-A levels have value as a prognostic biomarker in coronary heart disease patients and SNPs in VEGF-A deserve further investigation as prognostic markers and indicators of angiogenic potential influencing the formation of collateral circulation.
Keyphrases
- vascular endothelial growth factor
- endothelial cells
- end stage renal disease
- acute coronary syndrome
- ejection fraction
- chronic kidney disease
- newly diagnosed
- dna methylation
- prognostic factors
- genome wide
- transcription factor
- percutaneous coronary intervention
- patient reported outcomes
- risk assessment
- climate change
- atrial fibrillation